Episode Details

Back to Episodes

Guest: Cristiano Facanha of CALSTART on climate change transportation initiatives; Consumers distrust pharmaceutical supply chains; Tight freight capacity will continue well into 2022

Season 2 Episode 45 Published 4 years, 11 months ago
Description

Our guest in this week's episode is Dr. Cristiano Façanaha, global director at environmental advocacy group CALSTART. He is a transportation and environmental engineer and an expert at designing and evaluating sustainable transportation systems. The world just concluded the COP26 climate conference in Scotland. Out of that meeting came several international initiatives and commitments to reduce carbon emissions. A couple of these directly affect the trucking and transportation sectors. Our guest addresses what they are and what they mean for the industry.

Consumers don't trust pharmaceutical supply chains. They worry about counterfeit medicines sneaking into their medicine cabinets as well as possible damage and contamination of genuine medicines as they travel throughout the supply chain. What can the industry do to assure our medicines are safe and to restore public confidence in them?

We have experienced tight freight capacity throughout this year, and it looks like it will continue well into 2022. A shortage of trucks and drivers, along with surging demand from the holiday season, will mean that rates will stay high and available capacity will not improve for the foreseeable future.

DC Velocity's sister publication CSCMP's Supply Chain Quarterly has  a new 11-episode limited podcast series called the Top 10 Supply Chain Threats. Each week, a different threat to our supply chains is discussed, including capacity constraints, labor shortages, inflation and economics, weather-related issues, component and product shortages, digitalization, automation, and much more. Subscribe at your favorite podcast platform. Search "Top 10 Supply Chain Threats."


Articles and resources mentioned in this episode:

Podcast sponsored by: Ryder

Other links

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us